✦ LIBER ✦

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany

✍ Scribed by Damm, Oliver; Eichner, Martin; Rose, Markus Andreas; Knuf, Markus; Wutzler, Peter; Liese, Johannes Günter; Krüger, Hagen; Greiner, Wolfgang

Book ID: 125353145
Publisher: Springer
Year: 2014
Tongue: French
Weight: 516 KB
Volume: 16
Category: Article
ISSN: 1618-7598
DOI: 10.1007/s10198-014-0586-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN80 Cost-Effectiveness of Vaccinating

PIN80 Cost-Effectiveness of Vaccinating Children Aged 2-17 Years with Intranasal Live Attenuated Influenza Vaccine (LAIV) in Germany

✍ O. Damm; M.A. Rose; W. Greiner; M. Knuf; U. Wahn; H. Krüger; P. Wutzler; T. Scha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Public health impact and cost effectiven

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis

✍ Rose, J. ;Hawthorn, R. L ;Watts, B. ;Singer, M. E 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 182 KB

The safety and effectiveness of self-adm

The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults

✍ Ambrose, Christopher S.; Wu, Xionghua 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 190 KB

PIN46 Cost-Effectiveness and Public Heal

PIN46 Cost-Effectiveness and Public Health Impact of Pneumococcal Vaccination in Malaysia

✍ K.K. Lee; L.W. Hong; C.S. Roberts; V.W. Lee; E. Hon; D.R. Strutton 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness of live-attenuated in

Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres

✍ Clare L. Hibbert; Pedro A. Piedra; Kimmie K. McLaurin; Timo Vesikari; Josephine 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 166 KB

PIN34 INTRANASAL LIVE ATTENUATED (LAIV)

PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS

✍ J.E. Tarride; N. Burke; C. von Keyserlingk; D. O'Reilly; F. Xie; R. Goeree 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB